Practice Variability in Screening and Treating Pediatric Critical Illness Delirium: Survey

Salim Aljabari1, Cara Carter2, Shahzad Waheed1

  • 1Department of Child Health, University of Missouri-Columbia, Missouri, United States.

Insights

Pediatric delirium (PD) screening and treatment vary widely across US children's hospitals. The Cornell Assessment of Pediatric Delirium is common, but national guidelines are needed for consistent care.

Area of Science:

  • Pediatric Critical Care Medicine
  • Neuroscience
  • Clinical Practice Guidelines

Background:

  • Best practices for pediatric delirium (PD) screening and treatment remain undefined.
  • Current recommendations are based on limited studies and adult data.
  • Standardized approaches are lacking in pediatric critical care settings.

Purpose of the Study:

  • To survey Pediatric Critical Care Medicine fellowship directors regarding PD screening and treatment.
  • To identify current practices in large academic medical centers in the United States.
  • To highlight the need for standardized national guidelines for pediatric delirium.

Main Methods:

  • Cross-sectional survey of Pediatric Critical Care Medicine fellowship directors.
  • Data collection on screening tools and pharmacologic treatments for PD.
  • Analysis of reported practices across major US academic medical centers.

Main Results:

  • Significant variability exists in PD screening and treatment protocols.
  • The Cornell Assessment of Pediatric Delirium is the most frequently used screening tool.
  • Quetiapine is the most commonly utilized pharmacologic agent for PD treatment.

Conclusions:

  • There is a high degree of heterogeneity in pediatric delirium management.
  • A national guideline is essential to standardize screening, prevention, and treatment of PD.
  • Standardization will improve patient care and outcomes in pediatric critical care.